Nothing Special   »   [go: up one dir, main page]

Schachter et al., 1973 - Google Patents

Chlamydiae as agents of human and animal diseases

Schachter et al., 1973

View PDF
Document ID
16781909620822198662
Author
Schachter J
Storz J
Tarizzo M
Bögel K
Publication year
Publication venue
Bulletin of the World Health Organization

External Links

Snippet

A brief review is given of the properties, occurrence, and public health significance of chlamydiae in man and animals and of the diagnosis and control of chlamydial infections. Chlamydiae occur naturally in a large number of avian and mammalian species. Man is the …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviradae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • G01N33/56916—Enterobacteria, e.g. shigella, salmonella, klebsiella, serratia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Micro-organisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/0004—Screening or testing of compounds for diagnosis of disorders, assessment of conditions, e.g. renal clearance, gastric emptying, testing for diabetes, allergy, rheuma, pancreas functions

Similar Documents

Publication Publication Date Title
Harkinezhad et al. Chlamydophila psittaci infections in birds: a review with emphasis on zoonotic consequences
Lang Coxiellosis (Q fever) in animals
York et al. A new member of the psittacosis-lymphogranuloma group of viruses that causes infection in calves
Higgins Nine disease outbreaks associated with myxoviruses among ducks in Hong Kong
Vanrompay Avian chlamydiosis
Erickson et al. Interactions between viscerotropic velogenic Newcastle disease virus and pet birds of six species. I. Clinical and serologic responses, and viral excretion
WO1993006211A1 (en) Vaccine for mystery swine disease and method for diagnosis thereof
Schachter et al. Chlamydiae as agents of human and animal diseases
Vanrompay et al. Primary pathogenicity of an European isolate of Chlamydia psittaci from turkey poults
Galton Leptospirosis: epidemiology, clinical manifestations in man and animals, and methods in laboratory diagnosis
Saif et al. A small round virus associated with enteritis in turkey poults
Loa et al. Humoral and cellular immune responses in turkey poults infected with turkey coronavirus
Grist et al. Infections by organisms of psittacosis/lymphogranuloma venereum group in the West of Scotland
Bankowski et al. Isolation of a hemagglutinating agent distinct from Newcastle disease from the respiratory tract of chickens
Harrison et al. An epizootic of respiratory syncytial virus infection in a dairy herd
Roy et al. Unexpected Newcastle disease virus in day old commercial chicks and breeder hen
Wills Chlamydia zoonoses
Abd El-Ghany Avian chlamydiosis: a world-wide emerging and public health threat
Kleven et al. Epidemiologic and field observations on avian influenza in Minnesota turkeys
Mnikova et al. Bovine coronavirus: virus isolation, laboratory diagnostics and specific prevention
Stanford Raptors: infectious diseases
HU214739B (en) Process for the preparation of dog coronavirus vaccine
Bannister et al. Sporadic bovine encephalomyelitis in Canada
EVSTIFEEV et al. Study of The Immunobiological Properties of a New Chlamydia Isolate Obtained from Goats During Chlamydia Abortion.
Bideci Chlamydias as a Zooonosis and Antibiotic Resistance in Chlamydiae